TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment of Recurrent Merkel Cell Carcinoma
Source: Merkel Cell Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Merkel cell carcinoma (MCC) is a rare tumor. Recommendations and outcomes of various treatments for patients with MCC are included in many large case series [1-3][Level of evidence C2] and several single-arm phase II clinical trials.[4][Level of evidence C1] Treatment is usually individualized based on patient preference and the specifics of each case. Patients should strongly consider enrolling in clinical trials.
Source links and citations
Continue within this section
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice